Jason Konner

6.6k citations

122 papers · 4.0k indexed · 3 hit papers · h-index 31

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Virology top 1%
- HIV Research and Treatment

Papers in

Reproductive Medicine 74
- Ovarian cancer diagnosis and treatment 73
Obstetrics and Gynecology 20
- Endometrial and Cervical Cancer Treatments 20

Co-authors: Carol Aghajanian Nathaniel R. Landau Didier Trono Christopher Aiken Marc E. Lenburg Paul Sabbatini William P. Tew Martee L. Hensley
Journals: Journal of Clinical Oncology (39 papers)Gynecologic Oncology (29 papers)International Journal of Gynecological Cancer (11 papers)Annals of Oncology (7 papers)Clinical Cancer Research (5 papers)
Partner nations: United States Spain Italy

In The Last Decade

Jason Konner

120 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study 2023 · 220 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Journal of Clinical Oncology
2021 Annals of Oncology
1994 Cell

Peers

Countries citing papers authored by Jason Konner

Since Specialization

Citations

This map shows the geographic impact of Jason Konner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Konner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Konner more than expected).

Fields of papers citing papers by Jason Konner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Konner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Konner. The network helps show where Jason Konner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jason Konner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jason Konner Line = papers co-authored together Jason Konner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate Gynecologic Oncology ·Paul Johannet, Hani Saputri, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green, Robin Guo, Martee L. Hensley, Chrisann Kyi, Ying Liu, Vicky Makker, Maria M. Rubinstein, Paul Sabbatini, William P. Tew, Michael B. Foote, Britta Weigelt, Carol Aghajanian, Rachel N. Grisham, Harry W. Mayne	2025	0
2	A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer. Journal of Clinical Oncology ·Angela Green, Qin Zhou, Alexia Iasonos, Esther Váquez y del Árbol, Britta Weigelt, Lora H. Ellenson, Mayara Schueroff Siqueira, Michele Caresana, R. K. Minyazeva, Joseph P. Erinjeri, Iva Petkovska, Sarat Chandarlapaty, カズヒロサンドウ, Rachel N. Grisham, Jason Konner, Maria M. Rubinstein, William P. Tew, Tiffany A. Troso-Sandoval, Carol Aghajanian, Vicky Makker	2024	4
3	Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial International Journal of Gynecological Cancer ·Robert L. Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A. Matulonis	2024	11
4	A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2) Gynecologic Oncology ·Melissa Lumish, M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen, Claire F. Friedman, Rachel N. Grisham, Jason Konner, Chrisann Kyi, Maria M. Rubinstein, Tiffany A. Troso-Sandoval, Carol Aghajanian, Vicky Makker	2024	7
5	Reply to Z.R. McCaw et al Journal of Clinical Oncology ·Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Jiuzhou Wang, Alexander Korshunov, Brooke Esteves, Michael Method, Robert L. Coleman	2023	2
6	Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study Obstetrical & Gynecological Survey ·Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Jiuzhou Wang, Alexander Korshunov, Brooke Esteves, Michael Method, Robert L. Coleman	2023	4
7	Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study Journal of Clinical Oncology ·Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Jiuzhou Wang, Alexander Korshunov, Brooke Esteves, Michael Method, Robert L. Coleman Hit paper breakdown →	2023	220
8	Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission Cancers ·Beryl Manning‐Geist, Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn, Roosevelt Fabiano Moraes da Silva, William P. Tew, Nicholas J. Sarlis, Dmitriy Zamarin, María Elena Carrillo-Camacho, Ilaria Laface, R.B. Materikova, Jingjing Qi, Phillip Wong, Paul Sabbatini, Roisin E. O’Cearbhaill	2023	12
9	Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study (002) Gynecologic Oncology ·Robert L. Coleman, Ana Oaknin, Sandro Pignata, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Brooke Esteves, Michael Method, Domenica Lorusso, Ursula A. Matulonis	2023	1
10	Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition American Journal of Ophthalmology Case Reports ·William Foulsham, Sandra Wolf, Haya A Alamrani, Vicky Makker, Jason Konner, David H. Abramson, Jasmine H. Francis	2022	4
11	605P Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer Annals of Oncology ·F. Naaim-Bouvet, 晶岩韓, Ana Oaknin, Sandro Pignata, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, P Harter, Colin G. Murphy, Lucia Dovigo, В Г Хозин, Jessica Foss, Michael Method, Michael J. Birrer, Robert L. Coleman, U. Matulonis, David M. O’Malley	2022	5
12	Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination Cancer Immunology Immunotherapy ·Ryan Kahn, Govind Ragupathi, Qin Zhou, Alexia Iasonos, María Elena Carrillo-Camacho, Martee L. Hensley, Jason Konner, Vicky Makker, William P. Tew, Carol Aghajanian, Paul Sabbatini, Roisin E. O’Cearbhaill	2022	5
13	Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery Journal of Gynecologic Oncology ·Ying L. Liu, Olga T. Filippova, Qin Zhou, Alexia Iasonos, S. Dennis, Oliver Zivanovic, Yukio Sonoda, Ginger J. Gardner, Vance Broach, Roisin E. O’Cearbhaill, Jason Konner, Carol Aghajanian, Kara Long Roche, William P. Tew	2019	23
14	Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer Gynecologic Oncology ·Ying L. Liu, Qin Zhou, Alexia Iasonos, 佐々木庸, Claire F. Friedman, Jason Konner, Roisin E. O’Cearbhaill, Carol Aghajanian, Dmitriy Zamarin	2019	15
15	Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status Gynecologic Oncology ·Marina Stasenko, Paulina Cybulska, Carina Shelia Puspitasari, Vicky Makker, Jason Konner, Roisin E. O’Cearbhaill, Kaled M. Alektiar, Kathryn Beal, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, S. Dennis, Oliver Zivanovic, Mario M. Leitão, Karen A. Cadoo, William P. Tew	2019	25
16	A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer International Journal of Gynecological Cancer ·Marco Franceschi, David M. Hyman, Qin Zhou, Alexia Iasonos, William P. Tew, Carol Aghajanian, Vicky Makker, Martee L. Hensley, Jason Konner, Rachel N. Grisham, 伟俊刘, Roosevelt Fabiano Moraes da Silva, David R. Spriggs, Paul Sabbatini, Roisin E. O’Cearbhaill	2018	6
17	Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer Journal of Clinical Oncology ·Jason Konner, L. Geerts, Scott R. Gerst, Alexia Iasonos, Howard T. Thaler, S. Pezzulli, Paul Sabbatini, Katherine M. Bell‐McGuinn, William P. Tew, Martee L. Hensley, David R. Spriggs, Carol Aghajanian	2011	44
18	Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity Annals of Oncology ·David Gallagher, Jason Konner, K.M. Bell-McGuinn, Jasmine Bhatia, Paul Sabbatini, Carol Aghajanian, Kenneth Offit, R.R. Barakat, David R. Spriggs, Noah D. Kauff	2010	91
19	Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma Gynecologic Oncology ·John P. Diaz, William P. Tew, Oliver Zivanovic, Jason Konner, Paul Sabbatini, Sruthy Ab, Nadeem R. Abu‐Rustum, S. Dennis, Carol Aghajanian, Richard R. Barakat	2009	34
20	Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy International Journal of Gynecological Cancer ·Paul Sabbatini, David Mooney, Alexia Iasonos, Howard T. Thaler, Carol Aghajanian, Martee L. Hensley, Jason Konner, David R. Spriggs, Nadeem R. Abu‐Rustum, Jakob Dupont	2007	9

About Jason Konner

Jason Konner is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 122 papers that have together received 4.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (73 papers), Endometrial and Cervical Cancer Treatments (20 papers), Intraperitoneal and Appendiceal Malignancies (19 papers), HER2/EGFR in Cancer Research (12 papers), PARP inhibition in cancer therapy (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Reproductive Medicine (1.4k citations), Virology (571 citations), Obstetrics and Gynecology (536 citations), Oncology (1.8k citations) and Immunology (910 citations). Jason Konner has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Carol Aghajanian, Nathaniel R. Landau, Didier Trono, Christopher Aiken, Marc E. Lenburg, Paul Sabbatini, William P. Tew, Martee L. Hensley, David R. Spriggs and Ursula A. Matulonis. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, International Journal of Gynecological Cancer, Annals of Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact